Literature DB >> 11487644

Acute neuronal apoptosis in a rat model of multiple sclerosis.

R Meyer1, R Weissert, R Diem, M K Storch, K L de Graaf, B Kramer, M Bahr.   

Abstract

Demyelination caused by inflammation of the CNS has been considered to be a major hallmark of multiple sclerosis (MS). Using experimental autoimmune encephalomyelitis, a model of MS, we demonstrate that an immune-mediated attack of the optic nerve is accompanied by an early degeneration of retinal ganglion cells (RGCs). The decrease of neuronal cell density was correlated with functional disabilities as assessed by visual evoked cortical potentials and electroretinogram. Visual acuity was significantly reduced. DNA degradation and activation of caspase-3 in RGCs indicate that cell death of RGCs is apoptotic. These findings show for the first time that an inflammatory attack against myelin components can lead to acute neuronal cell loss by apoptosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11487644      PMCID: PMC6763179     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  49 in total

1.  Axonal changes in chronic demyelinated cervical spinal cord plaques.

Authors:  G Lovas; N Szilágyi; K Majtényi; M Palkovits; S Komoly
Journal:  Brain       Date:  2000-02       Impact factor: 13.501

2.  Axonal damage in acute multiple sclerosis lesions.

Authors:  B Ferguson; M K Matyszak; M M Esiri; V H Perry
Journal:  Brain       Date:  1997-03       Impact factor: 13.501

3.  Autoimmune encephalomyelitis ameliorated by AMPA antagonists.

Authors:  T Smith; A Groom; B Zhu; L Turski
Journal:  Nat Med       Date:  2000-01       Impact factor: 53.440

4.  Contrast sensitivity and visual acuity of the pigmented rat determined electrophysiologically.

Authors:  L C Silveira; C A Heywood; A Cowey
Journal:  Vision Res       Date:  1987       Impact factor: 1.886

5.  Experimental allergic encephalomyelitis. II. Retinal and other ocular manifestations.

Authors:  S S Hayreh
Journal:  Invest Ophthalmol Vis Sci       Date:  1981-08       Impact factor: 4.799

6.  Electroretinographic responses to alternating gratings before and after section of the optic nerve.

Authors:  L Mafei; A Fiorentini
Journal:  Science       Date:  1981-02-27       Impact factor: 47.728

7.  Immunospecific inhibition of nerve conduction by T lymphocytes reactive to basic protein of myelin.

Authors:  Y Yarom; Y Naparstek; V Lev-Ram; J Holoshitz; A Ben-Nun; I R Cohen
Journal:  Nature       Date:  1983 May 19-25       Impact factor: 49.962

Review 8.  Axonal pathology in multiple sclerosis: relationship to neurologic disability.

Authors:  B D Trapp; R Ransohoff; R Rudick
Journal:  Curr Opin Neurol       Date:  1999-06       Impact factor: 5.710

9.  MHC haplotype-dependent regulation of MOG-induced EAE in rats.

Authors:  R Weissert; E Wallström; M K Storch; A Stefferl; J Lorentzen; H Lassmann; C Linington; T Olsson
Journal:  J Clin Invest       Date:  1998-09-15       Impact factor: 14.808

Review 10.  Mechanisms of immune injury in multiple sclerosis.

Authors:  C F Brosnan; C S Raine
Journal:  Brain Pathol       Date:  1996-07       Impact factor: 6.508

View more
  64 in total

1.  Visual Evoked Potential Recording in a Rat Model of Experimental Optic Nerve Demyelination.

Authors:  Yuyi You; Vivek K Gupta; Nitin Chitranshi; Brittany Reedman; Alexander Klistorner; Stuart L Graham
Journal:  J Vis Exp       Date:  2015-07-29       Impact factor: 1.355

2.  Diffusion fMRI detects white-matter dysfunction in mice with acute optic neuritis.

Authors:  Tsen-Hsuan Lin; William M Spees; Chia-Wen Chiang; Kathryn Trinkaus; Anne H Cross; Sheng-Kwei Song
Journal:  Neurobiol Dis       Date:  2014-03-13       Impact factor: 5.996

Review 3.  Autoimmunity as the body's defense mechanism against the enemy within: Development of therapeutic vaccines for neurodegenerative disorders.

Authors:  Michal Schwartz
Journal:  J Neurovirol       Date:  2002-12       Impact factor: 2.643

4.  SIRT1 promotes RGC survival and delays loss of function following optic nerve crush.

Authors:  Ling Zuo; Reas S Khan; Vivian Lee; Kimberly Dine; Wen Wu; Kenneth S Shindler
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-07-26       Impact factor: 4.799

5.  Transgenic inhibition of astroglial NF-kappa B improves functional outcome in experimental autoimmune encephalomyelitis by suppressing chronic central nervous system inflammation.

Authors:  Roberta Brambilla; Trikaldarshi Persaud; Xianchen Hu; Shaffiat Karmally; Valery I Shestopalov; Galina Dvoriantchikova; Dmitry Ivanov; Lubov Nathanson; Scott R Barnum; John R Bethea
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

6.  Analysis of the pathogenesis of experimental autoimmune optic neuritis.

Authors:  Takeshi Kezuka; Yoshihiko Usui; Hiroshi Goto
Journal:  J Biomed Biotechnol       Date:  2010-10-25

7.  Animal model of human disease with optic neuritis: neuropapillitis in a rat model infected with Angiostrongylus cantonensis.

Authors:  Ying Feng; Xin Zeng; Wei-hua Li; Wen-cong Wang; Li-si Ou-Yang; Xi Sun; Zhiyue Lv; Zhong-Dao Wu
Journal:  Parasitol Res       Date:  2014-08-31       Impact factor: 2.289

8.  Experimental optic neuritis induced by a demyelinating strain of mouse hepatitis virus.

Authors:  Kenneth S Shindler; Lawrence C Kenyon; Mahasweta Dutt; Susan T Hingley; Jayasri Das Sarma
Journal:  J Virol       Date:  2008-06-25       Impact factor: 5.103

9.  Timing of corticosteroid therapy is critical to prevent retinal ganglion cell loss in experimental optic neuritis.

Authors:  Mahasweta Dutt; Philomela Tabuena; Elvira Ventura; Abdolmohamad Rostami; Kenneth S Shindler
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-11-05       Impact factor: 4.799

10.  Therapeutic effect of transplanted human Wharton's jelly stem cell-derived oligodendrocyte progenitor cells (hWJ-MSC-derived OPCs) in an animal model of multiple sclerosis.

Authors:  Elmira Mikaeili Agah; Kazem Parivar; Mohammad Taghi Joghataei
Journal:  Mol Neurobiol       Date:  2013-08-28       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.